Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by ANALIAS00on Oct 13, 2020 12:44pm

96 Views

Post# 31707534

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:The Never Ending Cycle

So institutionnals believe in the products and the potential, they will wait that SP jump tp 10$ before buying ? I just believe at this point they know THTX but are simply not interested at all. Maybe one day but clearly not short or mid term.

SPCEO1 wrote: Volume has been quite low since the news of the move into general NASH, which is the opposite of what one would rationally expect. Management is clearly having dificulty selling this stock to insitutional investors, and its small market cap is likely the biggest reason for that. Perhaps a retail-focused investor relations strategy would be more appropriate at this point, at least until the market cap rises to the level that allows institutions to buy the stock.

realitycheck4u wrote: It's a bit concerning and we seem to be the only cheerleaders. In fact I bought over 40,000 shares this afternoon and therefore the majority of shares. That's very strange.